Ankit Dwivedi

Ankit Dwivedi practices at Miami Valley Hospital in Dayton, Ohio, part of Premier Health.

Ankit Dwivedi's NPI, 1710361514, was assigned on July 13, 2015. Ankit Dwivedi holds Ohio license 35.132984.

Ankit Dwivedi's primary practice is Miami Valley Hospital, at One Wyoming Street, Dayton, OH 45409 in Montgomery County. The practice phone is (937) 208-3023. Ankit Dwivedi also practices at Miami Valley Hospital, 1 Wyoming St, Dayton, OH 45409.

Ankit Dwivedi's primary practice is Miami Valley Hospital in Dayton, Ohio, part of Premier Health. The medical group on file is Miami Valley Hospitalist Group. Dmand AI also links Ankit Dwivedi to 4 more group practices and clinics, 3 medical groups and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ankit Dwivedi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ankit Dwivedi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Ankit Dwivedi's licenses on file in 2 states: Ohio and New York.

CMS data shows 578 Medicare services from Ankit Dwivedi across 5 procedure codes in 2024, for 182 Medicare patients. Medicare paid $45,221 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 182 Medicare patients who saw Ankit Dwivedi in 2024. The largest group is 75 to 84, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ankit Dwivedi's median patient age at 72, with 53% women.

In 2024, Ankit Dwivedi wrote 284 Medicare Part D claims for 113 patients. 90% of them were for generic drugs. CMS names the drug for 50 of them, across 4 drugs with 11 or more claims each, at $390 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Ankit Dwivedi for performance year 2024, reported as part of a group. Ankit Dwivedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 27 papers to Ankit Dwivedi, published from 2014 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Malaria, Falciparum, Plasmodium falciparum and Antimalarials. Ankit Dwivedi has published most often in Malar J. Ankit Dwivedi's most frequent co-authors are Christopher V. Plowe, MD, Matthew Brent Laurens, MD and Kirsten Ellizabeth Lyke, MD.

CMS Open Payments shows 1 general payment to Ankit Dwivedi from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $118.